Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-49,325
Closed -$14M 41
2016
Q4
$14M Buy
+49,325
New +$14.6M 3.22% 15
2016
Q3
Sell
-14,722
Closed -$3.56M 40
2016
Q2
$3.56M Sell
14,722
-24,163
-62% -$6.37M 1.1% 23
2016
Q1
$10.1M Buy
38,885
+7,485
+24% +$1.98M 2.82% 15
2015
Q4
$9.62M Hold
31,400
2.33% 14
2015
Q3
$9.16M Buy
+31,400
New +$10.4M 1.78% 19

Other funds holding BIIB

SeaTown Holdings's BIIB Position: Q1 2017 in Review

SeaTown Holdings sold out of Biogen (BIIB) in Q1 2017, closing a stake of 49,325 shares — an estimated $14M sold.

SeaTown Holdings first reported a position in BIIB in Q3 2015 and held it in 5 quarters. The position peaked at $14M in Q4 2016. 1,020 funds tracked by Wall St. Rank hold BIIB as of Q1 2017.

  • SeaTown Holdings reported no remaining Biogen position as of Q1 2017 after selling out during the quarter.
  • SeaTown Holdings sold 49,325 Biogen shares in Q1 2017, an estimated $14M.
  • SeaTown Holdings first reported a position in Biogen in Q3 2015 and held it in 5 quarters.
  • SeaTown Holdings's Biogen position peaked at $14M in Q4 2016.
  • 1,020 funds tracked by Wall St. Rank held Biogen as of Q1 2017.

Based on SeaTown Holdings's 13F filing for Q1 2017, filed 28 Apr 2017.